Center for Immunization Research (CIR), Johns Hopkins School of Public Health

Baltimore, Maryland 21205

0 studies enrolling now · 3 studies all time

What they study most

Dengue, Paramyxoviridae Infections, Virus Diseases

Studies at this site

• Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2 — Completed
• Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine — Completed
• Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children — Completed